ImmuCell Corp (ICCC)
5.14
+0.04
(+0.78%)
USD |
NASDAQ |
Apr 26, 16:00
5.14
0.00 (0.00%)
After-Hours: 20:00
ImmuCell Revenue (TTM): 17.47M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 17.47M |
| September 30, 2023 | 16.29M |
| June 30, 2023 | 15.69M |
| March 31, 2023 | 16.01M |
| December 31, 2022 | 18.57M |
| September 30, 2022 | 20.10M |
| June 30, 2022 | 20.46M |
| March 31, 2022 | 21.14M |
| December 31, 2021 | 19.24M |
| September 30, 2021 | 17.54M |
| June 30, 2021 | 16.11M |
| March 31, 2021 | 14.54M |
| December 31, 2020 | 15.34M |
| September 30, 2020 | 15.23M |
| June 30, 2020 | 14.48M |
| March 31, 2020 | 14.22M |
| December 31, 2019 | 13.72M |
| September 30, 2019 | 13.03M |
| June 30, 2019 | 12.21M |
| March 31, 2019 | 12.52M |
| December 31, 2018 | 10.99M |
| September 30, 2018 | 11.18M |
| June 30, 2018 | 11.03M |
| March 31, 2018 | 9.768M |
| December 31, 2017 | 10.43M |
| Date | Value |
|---|---|
| September 30, 2017 | 9.512M |
| June 30, 2017 | 9.476M |
| March 31, 2017 | 10.10M |
| December 31, 2016 | 9.544M |
| September 30, 2016 | 10.02M |
| June 30, 2016 | 10.53M |
| March 31, 2016 | 10.11M |
| December 31, 2015 | 10.23M |
| September 30, 2015 | 9.740M |
| June 30, 2015 | 9.037M |
| March 31, 2015 | 8.617M |
| December 31, 2014 | 7.597M |
| September 30, 2014 | 6.951M |
| June 30, 2014 | 6.415M |
| March 31, 2014 | 6.242M |
| December 31, 2013 | 6.007M |
| September 30, 2013 | 5.869M |
| June 30, 2013 | 5.711M |
| March 31, 2013 | 5.520M |
| December 31, 2012 | 5.390M |
| September 30, 2012 | 5.274M |
| June 30, 2012 | 5.200M |
| March 31, 2012 | 5.273M |
| December 31, 2011 | 5.111M |
| September 30, 2011 | 4.930M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
12.21M
Minimum
Jun 2019
21.14M
Maximum
Mar 2022
16.39M
Average
16.01M
Median
Mar 2023
Revenue (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | 14.73M |
| Palatin Technologies Inc | 7.098M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |